| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
The use of estrogens and progestins and the risk of breast cancer in postmenopausal women.
|
N Engl J Med
|
1995
|
11.08
|
|
2
|
Differential changes in bone mineral density of the appendicular and axial skeleton with aging: relationship to spinal osteoporosis.
|
J Clin Invest
|
1981
|
3.60
|
|
3
|
Age changes and sex differences in serum dehydroepiandrosterone sulfate concentrations throughout adulthood.
|
J Clin Endocrinol Metab
|
1984
|
3.07
|
|
4
|
Source of estrogen production in postmenopausal women.
|
J Clin Endocrinol Metab
|
1973
|
2.91
|
|
5
|
A review of the prolonged use of estrogens and androgens in postmenopausal and senile osteoporosis.
|
AMA Arch Intern Med
|
1957
|
2.29
|
|
6
|
Marked decline in serum concentrations of adrenal C19 sex steroid precursors and conjugated androgen metabolites during aging.
|
J Clin Endocrinol Metab
|
1997
|
1.96
|
|
7
|
Skeletal effects of oral oestrogen compared with subcutaneous oestrogen and testosterone in postmenopausal women.
|
BMJ
|
1988
|
1.89
|
|
8
|
On aging bone loss.
|
Clin Orthop Relat Res
|
1982
|
1.86
|
|
9
|
Effects of replacement dose of dehydroepiandrosterone in men and women of advancing age.
|
J Clin Endocrinol Metab
|
1994
|
1.79
|
|
10
|
The key role of 17 beta-hydroxysteroid dehydrogenases in sex steroid biology.
|
Steroids
|
1997
|
1.76
|
|
11
|
Changes in serum concentrations of conjugated and unconjugated steroids in 40- to 80-year-old men.
|
J Clin Endocrinol Metab
|
1994
|
1.66
|
|
12
|
Intracrinology.
|
Mol Cell Endocrinol
|
1991
|
1.61
|
|
13
|
Endocrine and intracrine sources of androgens in women: inhibition of breast cancer and other roles of androgens and their precursor dehydroepiandrosterone.
|
Endocr Rev
|
2003
|
1.60
|
|
14
|
Dehydroepiandrosterone (DHEA), DHEA sulfate, and aging: contribution of the DHEAge Study to a sociobiomedical issue.
|
Proc Natl Acad Sci U S A
|
2000
|
1.51
|
|
15
|
Testosterone enhances estradiol's effects on postmenopausal bone density and sexuality.
|
Maturitas
|
1995
|
1.37
|
|
16
|
Stanozolol in postmenopausal osteoporosis: therapeutic efficacy and possible mechanisms of action.
|
Metabolism
|
1983
|
1.32
|
|
17
|
Clinical experience of drug treatments for mastalgia.
|
Lancet
|
1985
|
1.26
|
|
18
|
The management of persistent menopausal symptoms with oestradiol-testosterone implants: clinical, lipid and hormonal results.
|
Maturitas
|
1984
|
1.21
|
|
19
|
Modulation of growth, differentiation and carcinogenesis by dehydroepiandrosterone.
|
Adv Enzyme Regul
|
1987
|
1.18
|
|
20
|
Dehydroepiandrosterone enhances IL2 production and cytotoxic effector function of human T cells.
|
Clin Immunol Immunopathol
|
1991
|
1.17
|
|
21
|
Early menopausal changes in bone mass and sex steroids.
|
J Clin Endocrinol Metab
|
1985
|
1.16
|
|
22
|
Unique features of the basal cells of human prostate epithelium.
|
Microsc Res Tech
|
2000
|
1.16
|
|
23
|
Dehydroepiandrosterone reduces serum low density lipoprotein levels and body fat but does not alter insulin sensitivity in normal men.
|
J Clin Endocrinol Metab
|
1988
|
1.14
|
|
24
|
Localization of type 5 17beta-hydroxysteroid dehydrogenase, 3beta-hydroxysteroid dehydrogenase, and androgen receptor in the human prostate by in situ hybridization and immunocytochemistry.
|
Endocrinology
|
1999
|
1.14
|
|
25
|
Differential symptom response to parenteral estrogen and/or androgen administration in the surgical menopause.
|
Am J Obstet Gynecol
|
1985
|
1.11
|
|
26
|
Sex steroids and bone density in premenopausal and perimenopausal women.
|
J Clin Endocrinol Metab
|
1989
|
1.11
|
|
27
|
Physiological changes in dehydroepiandrosterone are not reflected by serum levels of active androgens and estrogens but of their metabolites: intracrinology.
|
J Clin Endocrinol Metab
|
1997
|
1.10
|
|
28
|
DHEA and peripheral androgen and estrogen formation: intracinology.
|
Ann N Y Acad Sci
|
1995
|
1.09
|
|
29
|
Therapeutic effects of dehydroepiandrosterone (DHEA) in diabetic mice.
|
Diabetes
|
1982
|
1.09
|
|
30
|
Dehydroepiandrosterone and androsterone levels in human plasma: effect of age and sex; day-to-day and diurnal variations.
|
J Clin Endocrinol Metab
|
1957
|
1.09
|
|
31
|
The role of androgen in the maintenance of sexual functioning in oophorectomized women.
|
Psychosom Med
|
1987
|
1.05
|
|
32
|
Oral dehydroepiandrosterone in physiologic doses modulates immune function in postmenopausal women.
|
Am J Obstet Gynecol
|
1993
|
1.03
|
|
33
|
Twenty-four-hour mean plasma testosterone concentration declines with age in normal premenopausal women.
|
J Clin Endocrinol Metab
|
1995
|
1.02
|
|
34
|
Effect of 12-month dehydroepiandrosterone replacement therapy on bone, vagina, and endometrium in postmenopausal women.
|
J Clin Endocrinol Metab
|
1997
|
1.02
|
|
35
|
Reduced testosterone and adrenal C19 steroid levels in obese men.
|
Metabolism
|
1995
|
1.01
|
|
36
|
Affective changes with estrogen and androgen replacement therapy in surgically menopausal women.
|
J Affect Disord
|
1988
|
0.96
|
|
37
|
Clinical, biochemical, radiographic, epidemiologic, and economic features of osteoporosis.
|
Orthop Clin North Am
|
1981
|
0.95
|
|
38
|
Vaginal atrophy in the postmenopausal woman. The importance of sexual activity and hormones.
|
JAMA
|
1983
|
0.94
|
|
39
|
High-affinity androgen binding and androgenic regulation of alpha 1(I)-procollagen and transforming growth factor-beta steady state messenger ribonucleic acid levels in human osteoblast-like osteosarcoma cells.
|
Endocrinology
|
1991
|
0.94
|
|
40
|
Metabolic effects of 12-month percutaneous dehydroepiandrosterone replacement therapy in postmenopausal women.
|
J Endocrinol
|
1996
|
0.89
|
|
41
|
Divergent correlations of circulating dehydroepiandrosterone sulfate and testosterone with insulin levels and insulin receptor binding.
|
J Clin Endocrinol Metab
|
1988
|
0.87
|
|
42
|
Role of 17 beta-hydroxysteroid dehydrogenases in sex steroid formation in peripheral intracrine tissues.
|
Trends Endocrinol Metab
|
2000
|
0.84
|
|
43
|
Prevention by dehydroepiandrosterone of the development of mammary carcinoma induced by 7,12-dimethylbenz(a)anthracene (DMBA) in the rat.
|
Breast Cancer Res Treat
|
1994
|
0.83
|
|
44
|
RU486, a progestin and glucocorticoid antagonist, inhibits the growth of breast cancer cells via the progesterone receptor.
|
J Clin Endocrinol Metab
|
1985
|
0.82
|
|
45
|
Effectiveness of dehydroepiandrosterone in reduction of cryptosporidial activity in immunosuppressed rats.
|
Antimicrob Agents Chemother
|
1992
|
0.82
|
|
46
|
Inhibition of tumor development by dehydroepiandrosterone and related steroids.
|
Toxicol Pathol
|
1986
|
0.82
|
|
47
|
Dehydroepiandrosterone (DHEA) and synthetic DHEA analogs are modest inhibitors of HIV-1 IIIB replication.
|
AIDS Res Hum Retroviruses
|
1992
|
0.80
|
|
48
|
Effects of nandrolone decanoate and antiresorptive therapy on vertebral density in osteoporotic postmenopausal women.
|
Arch Intern Med
|
1989
|
0.80
|
|
49
|
Androgenic activity of dehydroepiandrosterone and androstenedione in the rat ventral prostate.
|
Endocrinology
|
1988
|
0.79
|
|
50
|
Radioimmunoassay of 17beta-hydroxy-5alpha-androstan-3-one, 4-androstene-3,17-dione, dehydroepiandrosterone, 17-hydroxyprogesterone and progesterone and its application to the human male plasma.
|
J Steroid Biochem
|
1976
|
0.78
|
|
51
|
Influence of testosterone and dihydrotestosterone on bone-matrix induced endochondral bone formation.
|
Calcif Tissue Int
|
1989
|
0.78
|
|
52
|
Effects of parenteral administration of estrogen and androgen on plasma hormone levels and hot flushes in the surgical menopause.
|
Am J Obstet Gynecol
|
1984
|
0.78
|
|
53
|
Obesity in the dog: role of the adrenal steroid dehydroepiandrosterone (DHEA).
|
J Nutr
|
1991
|
0.77
|
|
54
|
Adrenocortical function in old age: response to acute adrenocorticotropin stimulation.
|
J Clin Endocrinol Metab
|
1982
|
0.75
|
|
55
|
Direct action of androgen on hot flushes in the human male.
|
Maturitas
|
1984
|
0.75
|
|
56
|
Exclusive androgenic effect of dehydroepiandrosterone in sebaceous glands of rat skin.
|
J Endocrinol
|
2000
|
0.75
|